ArticleInternational journal of nephrology2011
Acute kidney injury: controversies revisited.
Article in International journal of nephrology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Acute Kidney Injury: Medical Causes and Pathogenesis.Journal of clinical medicine · 2023Review
- Advances in the study of subclinical AKI biomarkers.Frontiers in physiology · 2022Review
- Peritoneal dialysis: Status report in South and South East Asia.Nephrology (Carlton, Vic.) · 2021Article
- External validation of the Madrid Acute Kidney Injury Prediction Score.Clinical kidney journal · 2021Article
- Development and Validation of a Model to Predict Severe Hospital-Acquired Acute Kidney Injury in Non-Critically Ill Patients.Journal of clinical medicine · 2021Article
- Association between Urinary Potassium Excretion and Acute Kidney Injury in Critically Ill Patients.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2021Article
- Lipocalin 2 enhances mesenchymal stem cell-based cell therapy in acute kidney injury rat model.Cytotechnology · 2018Article
- Urinary Biochemistry in the Diagnosis of Acute Kidney Injury.Disease markers · 2018Review
- Acute peritoneal dialysis in a Jehovah's Witness post laparotomy.BMJ case reports · 2016Article
- The potential use of biomarkers in predicting contrast-induced acute kidney injury.International journal of nephrology and renovascular disease · 2016Review
- Outcomes After Post-Traumatic AKI Requiring RRT in United States Military Service Members.Clinical journal of the American Society of Nephrology : CJASN · 2015Article
- A review of acute and chronic peritoneal dialysis in developing countries.Clinical kidney journal · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper addresses the epidemiology of AKI specifically in relation to recent changes in AKI classification and revisits the controversies regarding the timing of initiation of dialysis and the use of peritoneal dialysis as a renal replacement therapy for AKI. In summary, the new RIFLE/AKIN classifications of AKI have facilitated more uniform diagnosis of AKI and clinically significant risk stratification. Regardless, the issue of timing of dialysis initiation still remains unanswered and warrants further examination. Furthermore, peritoneal dialysis as a treatment modality for AKI remains underutilised in spite of potential beneficial effects. Future research should be directed at identifying early reliable biomarkers of AKI, which in conjunction with RIFLE/AKIN classifications of AKI could facilitate well-designed large randomised controlled trials of early versus late initiation of dialysis in AKI. In addition, further studies of peritoneal dialysis in AKI addressing dialysis dose and associated complications are required for this therapy to be accepted more widely by clinicians.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.